NEU 0.26% $15.57 neuren pharmaceuticals limited

Think some need to calm the farm here - keep composed and...

  1. 709 Posts.
    lightbulb Created with Sketch. 649
    Think some need to calm the farm here - keep composed and evaluate the unique nature of what Neuren have.


    NEU has a strong balance sheet: at times like this, that is king. We have enough cash to last 2-3 years from quarter end, if required;

    We are late stage with clear path to becoming profitable without the need to raise again, or partner in uncertain environment; and

    Our partner ACADIA has around A$1 b in the bank.


    Future CF and f/cast revenue is unchanged: We have unchanged demand - Covid19 doesn't cure Retts and/or FXS.

    Companies with the attributes above will rebound fast and hardest when financials markets recover and they will.

    At ~-70% from the recent 2020 high are we at the bottom ? Well that probably depends on the liquidity requirements of the register vs demand; but at around $85m EV we are in the zone to accumulate for sure.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.57
Change
-0.040(0.26%)
Mkt cap ! $1.990B
Open High Low Value Volume
$15.83 $15.87 $15.20 $8.124M 524.8K

Buyers (Bids)

No. Vol. Price($)
1 64 $15.49
 

Sellers (Offers)

Price($) Vol. No.
$15.58 597 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.